The Scientist

» C. difficile

Most Recent

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

image: Microbiome Teams Up Against <em>C. diff</em>

Microbiome Teams Up Against C. diff

By | July 14, 2015

Researchers build a mathematical model that can predict whether a mouse will be infected by Clostridium difficile based on the microbes found in its GI tract.

1 Comment

image: Fecal Pill Treats Gut Infection

Fecal Pill Treats Gut Infection

By | October 11, 2014

In a preliminary study, patients with recurring Clostridium difficile infections found relief from diarrhea by ingesting frozen fecal matter from healthy volunteers.

0 Comments

image: Fecal Pills

Fecal Pills

By | October 7, 2013

A study shows that fecal transplants in an oral capsule form are an effective treatment for Clostridium difficile infection.

1 Comment

image: Bacterial Cocktail Treats Infection

Bacterial Cocktail Treats Infection

By | October 29, 2012

Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.

2 Comments

image: Wrestling with Recurrent Infections

Wrestling with Recurrent Infections

By | May 1, 2011

Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.

6 Comments

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham